BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 31504409)

  • 1. The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study.
    Van't Klooster CC; Ridker PM; Hjortnaes J; van der Graaf Y; Asselbergs FW; Westerink J; Aerts JGJV; Visseren FLJ
    Eur Heart J; 2019 Dec; 40(48):3901-3909. PubMed ID: 31504409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes.
    Sharif S; Van der Graaf Y; Cramer MJ; Kapelle LJ; de Borst GJ; Visseren FLJ; Westerink J;
    Cardiovasc Diabetol; 2021 Nov; 20(1):220. PubMed ID: 34753497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein and risk of lung cancer.
    Chaturvedi AK; Caporaso NE; Katki HA; Wong HL; Chatterjee N; Pine SR; Chanock SJ; Goedert JJ; Engels EA
    J Clin Oncol; 2010 Jun; 28(16):2719-26. PubMed ID: 20421535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.
    Siemes C; Visser LE; Coebergh JW; Splinter TA; Witteman JC; Uitterlinden AG; Hofman A; Pols HA; Stricker BH
    J Clin Oncol; 2006 Nov; 24(33):5216-22. PubMed ID: 17114654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-Reactive Protein and Risk of Cardiovascular Events and Mortality in Patients with Various Cardiovascular Disease Locations.
    Burger PM; Pradhan AD; Dorresteijn JAN; Koudstaal S; Teraa M; de Borst GJ; van der Meer MG; Mosterd A; Ridker PM; Visseren FLJ;
    Am J Cardiol; 2023 Jun; 197():13-23. PubMed ID: 37218417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of C-reactive protein, smoking and lung cancer death in the Third National Health and Nutrition Examination Survey.
    Bittoni MA; Focht BC; Clinton SK; Buckworth J; Harris RE
    Int J Oncol; 2015 Oct; 47(4):1537-44. PubMed ID: 26323323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease.
    Burger PM; Koudstaal S; Mosterd A; Fiolet ATL; Teraa M; van der Meer MG; Cramer MJ; Visseren FLJ; Ridker PM; Dorresteijn JAN;
    J Am Coll Cardiol; 2023 Aug; 82(5):414-426. PubMed ID: 37495278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethnic differences in systemic inflammation: an investigation of C-reactive protein levels among Moroccan, Turkish and Dutch groups in the Netherlands.
    Ujcic-Voortman JK; Baan CA; Verhoeff AP; Krol A; Seidell JC
    Atherosclerosis; 2011 Oct; 218(2):511-6. PubMed ID: 21788019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney disease, inflammation, and cardiovascular disease risk in rheumatoid arthritis.
    Kochi M; Kohagura K; Shiohira Y; Iseki K; Ohya Y
    J Cardiol; 2018 Mar; 71(3):277-283. PubMed ID: 28969969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Cardiovascular Disease.
    Wang A; Liu J; Li C; Gao J; Li X; Chen S; Wu S; Ding H; Fan H; Hou S
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function.
    Gruppen EG; Riphagen IJ; Connelly MA; Otvos JD; Bakker SJ; Dullaart RP
    PLoS One; 2015; 10(9):e0139057. PubMed ID: 26398105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein: an independent predictor of cardiovascular disease in Aboriginal Australians.
    Wang Z; Hoy WE
    Aust N Z J Public Health; 2010 Jul; 34 Suppl 1():S25-9. PubMed ID: 20618287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and sudden cardiac death in a community-based population of older adults: the Cardiovascular Health Study.
    Hussein AA; Gottdiener JS; Bartz TM; Sotoodehnia N; DeFilippi C; See V; Deo R; Siscovick D; Stein PK; Lloyd-Jones D
    Heart Rhythm; 2013 Oct; 10(10):1425-32. PubMed ID: 23906927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.
    Pine SR; Mechanic LE; Enewold L; Chaturvedi AK; Katki HA; Zheng YL; Bowman ED; Engels EA; Caporaso NE; Harris CC
    J Natl Cancer Inst; 2011 Jul; 103(14):1112-22. PubMed ID: 21685357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic inflammation and risk of lung cancer in older adults in the health, aging and body composition cohort study.
    Demb J; Wei EK; Izano M; Kritchevsky S; Swede H; Newman AB; Shlipak M; Akinyemiju T; Gregorich S; Braithwaite D
    J Geriatr Oncol; 2019 Mar; 10(2):265-271. PubMed ID: 30078713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline high-sensitivity C-reactive protein predicts the risk of incident ankylosing spondylitis: Results of a community-based prospective study.
    Su J; Cui L; Yang W; Shi H; Jin C; Shu R; Li H; Zeng X; Wu S; Gao X
    PLoS One; 2019; 14(2):e0211946. PubMed ID: 30768617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported cardiovascular disease and the risk of lung cancer, the HUNT study.
    Hatlen P; Langhammer A; Carlsen SM; Salvesen Ø; Amundsen T
    J Thorac Oncol; 2014 Jul; 9(7):940-946. PubMed ID: 24852520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study.
    Persson M; Engström G; Björkbacka H; Hedblad B
    Atherosclerosis; 2012 Feb; 220(2):502-5. PubMed ID: 22119508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study.
    Tuomisto K; Jousilahti P; Sundvall J; Pajunen P; Salomaa V
    Thromb Haemost; 2006 Mar; 95(3):511-8. PubMed ID: 16525580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study.
    Meisinger C; Koenig W; Baumert J; Döring A
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1186-92. PubMed ID: 18356554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.